The national moroccan registry of ST-elevation myocardial infarction (MR-MI)
Aida Soufiani1, Hamza Chraibi2, Ilyasse Asfalou3
1Cardiology A Department, Ibn Sina Hospital University Centre, Mohammed V University, Rabat, Morocco.
Insights
The Moroccan Myocardial Infarction-Myocardial Infarction (MR-MI) registry reveals delays in ST-elevation myocardial infarction (STEMI) care. Less than half of eligible patients receive timely revascularization, indicating a need for improved STEMI diagnosis and treatment strategies.
Area of Science:
- Cardiology
- Public Health
- Clinical Research
Background:
- The MR-MI registry is the inaugural national registry for ST-elevation myocardial infarction (STEMI) in Morocco.
- It aims to evaluate patient management and characterize STEMI's clinical and therapeutic aspects across Moroccan cardiology centers.
Purpose of the Study:
- To assess patient management modalities for STEMI in Morocco.
- To highlight the clinical and therapeutic characteristics of STEMI on a national scale.
Main Methods:
- Adult patients with STEMI within 5 days of symptom onset were enrolled from April to August 2018.
- Data were collected from 57 centers in 22 cities, covering 70% of Moroccan STEMI-treating facilities.
- Sociodemographic, clinical, management, revascularization, and follow-up data were gathered using electronic and paper case report forms.
Main Results:
- 809 patients were recruited, predominantly male (74.8%) with an average age of 62.6 years.
- Key risk factors included smoking (38.3%), hypertension (30.7%), and diabetes (28%).
- Only 30% of patients were admitted within 6 hours, and 49.6% received early revascularization, with in-hospital and one-month mortality rates of 5.2% and 3.2%, respectively.
Conclusions:
- MR-MI is the first national STEMI registry in Morocco.
- Management delays are significant compared to international standards, with less than 50% of timely presenting patients receiving early revascularization.
- Further efforts are required to optimize STEMI diagnosis and treatment in Morocco.
Background:
MR-MI is the first national Moroccan ST-elevation myocardial infarction (STEMI) registry. Its objectives are to assess patient management modalities and highlight the clinical and therapeutic characteristics of this pathology in all cardiology centres on a national scale.
Methods:
Adult patients presenting with STEMI within 5 days of symptoms onset were enrolled over a period of 18 weeks from April to August 2018. 57 cardiology centres distributed in 22 cities in Morocco participated in the study, including 5 university hospitals, representing 70% of Moroccan centres managing STEMI patients. A case report form was sent to the investigators in both electronic and paper forms. Sociodemographic, clinical, management, revascularization, and follow-up data were collected.
Results:
A total of 809 patients were recruited. The population was mostly male (74.8%) with an average age of 62.6 ± 11.6 years. The most common risk factors were smoking (38.3%) arterial hypertension (30.7%), and diabetes (28%). 30% of patients were admitted within the first 6 h of symptoms onset and early revascularization was performed on 49.6%. Mortality rate was 5.2% in-hospital and 3.2% at the one-month follow-up.
Conclusion:
MR-MI is the first Moroccan STEMI registry on a national scale. Relevant management delays are much longer than other countries, and less than 50% of the patients that present on time benefit from early revascularization. Efforts remain to be done on the optimal diagnosis and treatment of STEMI.
More Related Videos
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
10:01Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
Published on: March 12, 2018
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Imaging Studies for Cardiovascular System IV: CMRI
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Angina III: Clinical Manifestations and Assessment
